Retinitis Pigmentosa
210
33
53
99
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
31 trials with published results (15%)
Research Maturity
99 completed trials (47% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
7.6%
16 terminated out of 210 trials
86.1%
-0.4% vs benchmark
6%
12 trials in Phase 3/4
31%
31 of 99 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 99 completed trials
Clinical Trials (210)
Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants
Expanded Access Program for RP in Adults
A Study of AAV5-hRKp.RPGR for the Treatment of Japanese Participants With X-linked Retinitis Pigmentosa
Natural History of PRPF31 Mutation-Associated Retinal Dystrophy
Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)
Rod and Cone Mediated Function in Retinal Disease
Cell Collection to Study Eye Diseases
Development and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherited Retinal Disease (DEFINE-IRD)
Safety and Efficacy Study of Novel Gene Therapy ZM-02 for Retinitis Pigmentosa Patients
A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis Pigmentosa
Rate of Progression in EYS Related Retinal Degeneration
Oral N-acetylcysteine for Retinitis Pigmentosa
Electro-acupuncture and Transcorneal Electrical Stimulation (TES) for Retinitis Pigmentosa
A Prospective, Observational Study in Adults With Retinitis Pigmentosa (RP)
Role of UC-MSC and CM to Inhibit Vision Loss in Retinitis Pigmentosa Phase I/II
Long-term Safety of UC-MSC Transplantation in Patients With Retinitis Pigmentosa
Study to Evaluate Safety of RTx-015 Injection in Retinitis Pigmentosa or Choroideremia Patients (ENVISION)
A Phase 1/2 Study in Healthy Volunteers and Participants With Autosomal Dominant Retinitis Pigmentosa (RHO-adRP)
Rate of Progression of PCDH15-Related Retinal Degeneration in Usher Syndrome 1F
Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy